CellWell record HH-522208
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication
Wee CC; Phillips RS; Aurigemma G; Erban S; Kriegel G; Riley M; Douglas PS
Annals of internal medicine ยท 1998
In plain language
In 46 patients using fenfluramine or dexfenfluramine with pre-treatment echocardiograms, 4.3% of fenfluramine-phentermine users developed valvular heart disease, a rate possibly lower than previously reported.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-522208
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.